Literature DB >> 8592422

Biochemical assay of collagen and elastin in the normal and varicose vein wall.

M Venturi1, L Bonavina, F Annoni, L Colombo, C Butera, A Peracchia, E Mussini.   

Abstract

Alterations of the connective tissue in the varicose vein wall have been noted by several investigators; however, the cause of the vein dilatation has still not been established. The aim of this study was to find a biochemical explanation to the development of varices by evaluating sensitive biochemical markers of collagen and elastin in the varicose vein wall. 4-L-Hydroxyproline (HYP), as a marker of collagen content, and desmosine (DES) and isodesmosine (IDES), as markers of elastin, were measured in 47 macroscopically dilated and 32 nondilated segments of 20 varicose saphenous veins collected from 20 patients with varices. The same measurements were made in 24 fragments of normal saphenous veins collected from 14 patients in whom the vein was removed to be used for graft procedures. HYP (collagen) and DES and IDES (elastin) were determined with a colorimetric method and HPLC, respectively. ANOVA test was used to compare mean values (+/- SD). HYP and collagen content were similar in varicose and normal veins. There was a significant reduction of both DES and IDES in dilated segments of varicose veins (P < 0.05 vs normal veins and nondilated segments); the ratio of elastin to collagen was lower in varicose than normal veins (P < 0.05), and this reduction was most significant in the dilated segments (P < 0.01 vs normal veins). These results suggest that dilatation of the varicose vein wall may be related to some defect of elastin metabolism. Further studies on the metabolic activity of vein muscle cells are required.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8592422     DOI: 10.1006/jsre.1996.0038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

1.  Role of Rho kinase signalling in healthy and varicose human saphenous veins.

Authors:  Chrystelle Cario-Toumaniantz; Sandrine Evellin; Séverine Maury; Olivier Baron; Pierre Pacaud; Gervaise Loirand
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 2.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 3.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 4.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

Review 5.  Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.

Authors:  Joseph D Raffetto; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

6.  Flow cytometric characterization of the saphenous veins endothelial cells in patients with chronic venous disease and in patients undergoing bypass surgery: an exploratory study.

Authors:  Cláudia Torres; Rui Machado; Margarida Lima
Journal:  Heart Vessels       Date:  2019-06-21       Impact factor: 2.037

Review 7.  Mechanical Properties of Diseased Veins.

Authors:  Dragoslava P Vekilov; K Jane Grande-Allen
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

Review 8.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

9.  Expression of elastic components in healthy and varicose veins.

Authors:  Julia Buján; María J Gimeno; Jose A Jiménez; Cay M Kielty; Robert P Mecham; Juan M Bellón
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

10.  Hemodynamic Shear Stress and Endothelial Dysfunction in Hemodialysis Access.

Authors:  Michelle K Fitts; Daniel B Pike; Kasey Anderson; Yan-Ting Shiu
Journal:  Open Urol Nephrol J       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.